Menopausal oestrogen use and breast cancer.

Menopausal oestrogen use and breast cancer.

Mostrar otras versiones (1)

Detalles Bibliográficos
Autor principal:	Beral, V
Formato:	Journal article
Lenguaje:	English
Publicado:	1980

Ejemplares similares

Menopausal oestrogen use and breast cancer.
por: Beral, V
Publicado: (1980)

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment.
por: Cogliano, V, et al.
Publicado: (2005)

Complex role of oestrogens in the risk and severity of rheumatoid arthritis in menopause
por: Maurizio Cutolo, et al.
Publicado: (2023-04-01)

Oestrogen exposure and breast cancer risk.
por: Travis, R, et al.
Publicado: (2003)

Impact of mutational profiles on response of primary oestrogen receptor-positive breast cancers to oestrogen deprivation
por: Pascal Gellert, et al.
Publicado: (2016-11-01)

Cigarette smoking and urinary oestrogen excretion in premenopausal and post-menopausal women.
por: Key, T, et al.
Publicado: (1996)

Oestrogen enforces the integrity of blood vessels in the bone during pregnancy and menopause
por: Rodrigues, J, et al.
Publicado: (2022)

Menopausal hormone therapy and 20-year breast cancer mortality
por: Beral, V, et al.
Publicado: (2019)

The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.
por: Key, T, et al.
Publicado: (1988)

Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women.
por: Key, T
Publicado: (2011)

Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women
por: Key, T
Publicado: (2011)

Activation of rapid oestrogen signalling in aggressive human breast cancers
por: Coralie Poulard, et al.
Publicado: (2012-10-01)

A-FABP and oestrogens are independently involved in the development of breast cancer
por: Bing Li, et al.
Publicado: (2019-01-01)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
por: Beral, V, et al.
Publicado: (2011)

Correction to: Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1
por: Kheng Tian Lim, et al.
Publicado: (2018-06-01)

Oestrogen deprivation induces chemokine production and immune cell recruitment in in vitro and in vivo models of oestrogen receptor-positive breast cancer
por: Jody Hazlett, et al.
Publicado: (2021-10-01)

A prospective study of urinary oestrogen excretion and breast cancer risk.
por: Key, T, et al.
Publicado: (1996)

Oestrogen receptor activity in hormone-dependent breast cancer during chemotherapy
por: Nuria Chic, et al.
Publicado: (2021-07-01)

The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial
por: Meade Tom W, et al.
Publicado: (2007-02-01)

The role of oestrogen and oestrogen-calcium axis in endometrial carcinoma
por: Jingyi Zhou, et al.
Publicado: (2024-04-01)

Efficacy of neoadjuvant endocrine therapy compared with neoadjuvant chemotherapy in pre-menopausal patients with oestrogen receptor-positive and HER2-negative, lymph node-positive breast cancer
por: Hee Jeong Kim, et al.
Publicado: (2020-05-01)

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
por: Fergus J. Couch, et al.
Publicado: (2016-04-01)

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
por: Couch, FJ, et al.
Publicado: (2016)

Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
por: Javed, SR, et al.
Publicado: (2024)

Elucidation of Dysregulated Pathways Associated With Hypoxia in Oestrogen Receptor‐Negative Breast Cancer
por: Suad A. K. Shamis, et al.
Publicado: (2024-12-01)

Expression and clinical significance of CCN5 and the oestrogen receptor in advanced breast cancer
por: Guofeng Zhou, et al.
Publicado: (2025-02-01)

Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.
por: Rayoo, M, et al.
Publicado: (2009)

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.
por: Kaaks, R, et al.
Publicado: (2005)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
por: Reeves, G, et al.
Publicado: (2006)

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
por: Neil Carleton, BS, et al.
Publicado: (2022-01-01)

Oestrogen receptors and breast cancer. are we prepared to move forward? A critical review
por: Eraso, Yolanda
Publicado: (2020)

Expression of RET is associated with Oestrogen receptor expression but lacks prognostic significance in breast cancer
por: Robert Mechera, et al.
Publicado: (2019-01-01)

Relations between breast cancer risk and endogenous sex hormones (oestrogen, androgens, progesterone)
por: Key, T
Publicado: (2003)

Oestrogen Receptor Positive Metastatic Eccrine Porocarcinoma: A Case Report and Review of Anti-Oestrogen Therapy in Rare Cancers
por: Anita J.M. Kalakonda, et al.
Publicado: (2024-03-01)

A-kinase anchoring protein BIG3 coordinates oestrogen signalling in breast cancer cells
por: Tetsuro Yoshimaru, et al.
Publicado: (2017-05-01)

Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer.
por: Andrew Stone, et al.
Publicado: (2012-01-01)

Probing the link between oestrogen receptors and oesophageal cancer
por: Khan Raheela N, et al.
Publicado: (2010-02-01)

Structure and mechanism of the oestrogen receptor
por: Kong, E, et al.
Publicado: (2003)

Structure and mechanism of the oestrogen receptor.
por: Kong, E, et al.
Publicado: (2003)

Multiple Routes to Oestrogen Antagonism
por: Hilary R. Glover, et al.
Publicado: (2010-10-01)